Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

New tubulin polymerization inhibitors covered by Cytopia patent

Aug. 4, 2004

New cinnoline-based antitumor agents in early development at Nippon Kayaku

Aug. 4, 2004

Louisiana State University and Bionomics enter cancer gene therapy agreement

Aug. 3, 2004

Gemzar combination therapy receives European approvals for ovarian cancer

Aug. 2, 2004

Novel HDAC inhibitors in early development at Roche

Aug. 2, 2004

Antitumor colchicine derivatives prepared at Aventis

Aug. 2, 2004

Photodynamic therapy with Metvix shows efficacy in actinic cheilitis

July 30, 2004

Assessment of Bcl -2 family members as targets for antisense therapy in melanoma

July 30, 2004

Plantacor licenses preclinical cancer therapeutics from M. D. Anderson

July 30, 2004

Alimta receives positive endorsement from Advisory Committee for NSCLC

July 30, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 8, 2026.
First measles treatment advances as vaccination rates drop
BioWorld
Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
Infensa Bioscience identifies new ASIC blockers
BioWorld Science
Infensa Bioscience Pty Ltd. has patented new acid-sensing ion channel 1 (ASIC) blockers potentially useful for the treatment of stroke, among others.
Hantavirus is ‘sentinel’ more than acute pandemic threat
BioWorld
News of eight infections and three deaths so far due to an emerging zoonotic virus has brought back unhappy memories of the early days of SARS-CoV-2. At a press...
Italy’s Angelini pays $4.1B cash for rare disease specialist Catalyst
BioWorld
Italian family-owned Angelini Pharma SpA is making its first move into the U.S. market, acquiring rare diseases specialist Catalyst Pharma Inc. in an all-cash...